Microbiology

Study Improves Understanding of E. coli H30 Epidemiology, Persistent Infections Remains Unexplained
Researchers have identified populations more vulnerable to infection with pandemic E. coli strain H30, however improved testing is needed to monitor patients due to the high rate of treatment failure. Antibiotic resistance and weakened immunity only partially explain persistent infection. More...05 May 2016

Blood Transfusions in Malaria Zones Made Safer
Patients, especially children, who undergo blood transfusions in sub-Saharan Africa, are at high risk of transfusion-transmitted malaria. Every year, approximately 214 million people worldwide are infected with acute malaria, the majority of whom are in Africa and the disease is caused by the parasite Plasmodium. More...03 May 2016

MALDI-TOF Mass Spectrometry Differentiates Streptococcus Species
It is clinically relevant to distinguish Streptococcus pneumoniae from other less virulent, members of the viridans group streptococci (VGS) and accurate species determination within the VGS and more specifically within the mitis subgroup is traditionally difficult. More...02 May 2016

Molecular Diagnostics Identify Resistance Biomarkers of Bloodstream Infection
Molecular diagnostics allow for rapid identification and detection of resistance markers of bloodstream infection, with a potential for accelerated antimicrobial optimization and improved patient outcomes. More...02 May 2016

New Assay Improves Detection Of Deadly Prion Diseases
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a family of rare progressive, neurodegenerative illnesses that affect both humans and animals and TSE surveillance is important for public health and food safety. More...28 Apr 2016

Prototype Rapid Diagnostic Test Detects Human African Trypanosomiasis
Early diagnosis and treatment of human African trypanosomiasis (HAT) is essential for safe and effective treatment but the tests used to screen suspected patients and populations at risk are difficult to implement in remote rural settings where the disease occurs. More...27 Apr 2016

Group A Streptococcus Rapid Immunoassay Evaluated
Clinical reasoning utilizing certain symptoms and scores has not proven to be a reliable decision-making tool to determine whether or not to suspect a group A Streptococcus (GAS) infection in the patient presenting with a sore throat. More...27 Apr 2016
In Other News
Tuberculosis Elimination at Stake
Multiple STIs Could Be Detected with A Single Rapid Test
Immunoassay Detects Severe Fever with Thrombocytopenia Syndrome Virus
On-the-Go Microfluidics Device May Provide Better Diagnostics of HIV/HCV
Novel Multiplex Immunoassay Developed for Chagas Disease
Profiling Persistent Tubercle Bacilli Predicts Early Drug Efficacy
Acid-Fast Stain Identifies Schistosoma Eggs
Immunoassay for Human Cystic Echinococcosis Evaluated
Dedicated Blood Culture Diagnostics Cartridge Set for CE-IVD Marketing Release
Uninfected or Asymptomatic? – Key to Forecasting Infectious Disease Epidemics
Automated Ebola Blood Test Performs Well in Field Evaluation
Genomic Sequencing Identifies Deadly Bloodstream Infection
Shiga Toxin Direct Test Receives FDA Clearance
High Risk HPV Multiplex Assay Clinically Validated
Emerging Blood-Borne Bacteria Found in Blood Donors
Novel Malaria Test Sets a New Gold Standard for Diagnosis
Dried Cerebrospinal Fluid Spots Detect Anti-Japanese Encephalitis IgM
Uropathogenic Bacteria Linked to Deadly Disease in Preterm Infants
Immune Cells Adapt Inefficiently in Patients with Uncontrolled HIV
Methods Compared for Detection of Fecal Giardiasis
Innovative Nano-Biosensor Developed for Rapid Detection of Viruses
Rapid Low Cost Urine Test Diagnoses Tuberculosis, Reduces Mortality
FDA-Cleared Test Detects Carbapenem Resistance Genes
The LabMedica Microbiology channel provides the latest news in the fields of epidemiology, bacteriology, virology, and parasitology, all viewed from the unique perspective of Laboratory Medicine.







